174 related articles for article (PubMed ID: 2096929)
1. Vancomycin absorption from the peritoneal cavity during dialysis-related peritonitis.
Rubin J
Perit Dial Int; 1990; 10(4):283-5. PubMed ID: 2096929
[TBL] [Abstract][Full Text] [Related]
2. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.
Mactier RA; Moore H; Khanna R; Shah J
Nephron; 1990; 54(3):240-4. PubMed ID: 2179758
[TBL] [Abstract][Full Text] [Related]
3. Tobramycin absorption from the peritoneal cavity.
Rubin J
Perit Dial Int; 1990; 10(4):295-7. PubMed ID: 2096932
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis.
Rubin J; Ray R; Barnes T; Bower J
Nephron; 1981; 29(3-4):124-7. PubMed ID: 7329486
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
Brown J; Altmann P; Cunningham J; Shaw E; Marsh F
J Antimicrob Chemother; 1990 Jan; 25(1):141-7. PubMed ID: 2318749
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ
Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331
[TBL] [Abstract][Full Text] [Related]
8. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.
Mulhern JG; Braden GL; O'Shea MH; Madden RL; Lipkowitz GS; Germain MJ
Am J Kidney Dis; 1995 Apr; 25(4):611-5. PubMed ID: 7702059
[TBL] [Abstract][Full Text] [Related]
9. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
[TBL] [Abstract][Full Text] [Related]
10. Absorption of intraperitoneal antibiotics.
Morse GD; Apicella MA; Walshe JJ
Drug Intell Clin Pharm; 1988 Jan; 22(1):58-61. PubMed ID: 3349922
[TBL] [Abstract][Full Text] [Related]
11. Transfer of autologous haemoglobin from the peritoneal cavity during peritoneal dialysis.
Brouard R; Tozer TN; Baumelou A; Gambertoglio JG
Nephrol Dial Transplant; 1992; 7(1):57-62. PubMed ID: 1316582
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
Montañés Pauls B; Almiñana MA; Casabó Alós VG
Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
[TBL] [Abstract][Full Text] [Related]
13. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
Bailie GR; Eisele G; Venezia RA; Yocum D; Hollister A
Clin Pharmacokinet; 1992 Apr; 22(4):298-307. PubMed ID: 1606789
[TBL] [Abstract][Full Text] [Related]
14. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.
Gordon DL; Rice JL; Avery VM
Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088
[TBL] [Abstract][Full Text] [Related]
15. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
Møller JK; Hagelskjaer LH
Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
Davies SJ; Bryan J; Phillips L; Russell GI
Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
[TBL] [Abstract][Full Text] [Related]
17. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis.
Krothapalli RK; Senekjian HO; Ayus JC
Am J Med; 1983 Aug; 75(2):345-8. PubMed ID: 6881188
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
Whitby M; Edwards R; Aston E; Finch RG
J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
[TBL] [Abstract][Full Text] [Related]
20. Once weekly intraperitoneal therapy for gram-positive peritonitis.
Morse GD; Nairn DK; Walshe JJ
Am J Kidney Dis; 1987 Oct; 10(4):300-5. PubMed ID: 3661551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
